[PDF][PDF] VSL# 3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet‐induced nonalcoholic steatohepatitis model in mice
A Velayudham, A Dolganiuc, M Ellis, J Petrasek… - …, 2009 - Wiley Online Library
Nonalcoholic fatty liver disease (NAFLD) and its advanced stage, nonalcoholic
steatohepatitis (NASH), are the most common causes of chronic liver disease in the United …
steatohepatitis (NASH), are the most common causes of chronic liver disease in the United …
[HTML][HTML] Probiotics VSL# 3 are effective in reversing non-alcoholic steatohepatitis in a mouse model
Background Probiotic VSL# 3 is used to treat ulcerative colitis. This study examines the
effect of VSL# 3 in non-alcoholic steatohepatitis (NASH) that has liver carcinogenic potential …
effect of VSL# 3 in non-alcoholic steatohepatitis (NASH) that has liver carcinogenic potential …
Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: new insight into the probiotics for the gut-liver axis
H Endo, M Niioka, N Kobayashi, M Tanaka… - PloS one, 2013 - journals.plos.org
Nonalcoholic fatty liver disease (NAFLD) includes simple steatosis, nonalcoholic
steatohepatitis (NASH), fibrosis, cirrhosis, and hepatocellular carcinoma. The gut-derived …
steatohepatitis (NASH), fibrosis, cirrhosis, and hepatocellular carcinoma. The gut-derived …
The Effect of Probiotics (MCP® BCMC® Strains) on Hepatic Steatosis, Small Intestinal Mucosal Immune Function, and Intestinal Barrier in Patients with Non …
MH Mohamad Nor, N Ayob, NM Mokhtar, RA Raja Ali… - Nutrients, 2021 - mdpi.com
Treatment for non-alcoholic fatty liver disease (NAFLD) currently consists of lifestyle
modifications such as a low-fat diet, weight loss, and exercise. The gut microbiota forms part …
modifications such as a low-fat diet, weight loss, and exercise. The gut microbiota forms part …
Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease
Z Li, S Yang, H Lin, J Huang, PA Watkins, AB Moser… - Hepatology, 2003 - journals.lww.com
Ob/ob mice, a model for nonalcoholic fatty liver disease (NAFLD), develop intestinal
bacterial overgrowth and overexpress tumor necrosis factor α (TNF-α). In animal models for …
bacterial overgrowth and overexpress tumor necrosis factor α (TNF-α). In animal models for …
New insights into the pathogenesis of non-alcoholic fatty liver disease: gut-derived lipopolysaccharides and oxidative stress
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease
worldwide. The intricate NAFLD pathogenesis is summarized by the multiple-hits …
worldwide. The intricate NAFLD pathogenesis is summarized by the multiple-hits …
Nonalcoholic fatty liver disease is exacerbated in high-fat diet-fed gnotobiotic mice by colonization with the gut microbiota from patients with nonalcoholic …
CC Chiu, YH Ching, YP Li, JY Liu, YT Huang… - Nutrients, 2017 - mdpi.com
Nonalcoholic fatty liver disease (NAFLD) is a serious liver disorder associated with the
accumulation of fat and inflammation. The objective of this study was to determine the gut …
accumulation of fat and inflammation. The objective of this study was to determine the gut …
Effects of a Lactobacillus paracasei B21060 based synbiotic on steatosis, insulin signaling and toll-like receptor expression in rats fed a high-fat diet
Insulin resistance (IR) has been identified as crucial pathophysiological factor in the
development and progression of non-alcoholic fatty liver disease (NAFLD). Although …
development and progression of non-alcoholic fatty liver disease (NAFLD). Although …
Role of probiotics in non-alcoholic fatty liver disease: does gut microbiota matter?
C Xie, D Halegoua-DeMarzio - Nutrients, 2019 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) is the hepatic consequence of metabolic
syndrome, which often also includes obesity, diabetes, and dyslipidemia. The connection …
syndrome, which often also includes obesity, diabetes, and dyslipidemia. The connection …
Probiotic mixture improves fatty liver disease by virtue of its action on lipid profiles, leptin, and inflammatory biomarkers
HM Al-Muzafar, KA Amin - BMC complementary and alternative medicine, 2017 - Springer
Background A high fat diet has an essential role in the pathogenesis of non-alcoholic fatty
liver disease (NAFLD). This condition is characterized by hepatic fat accumulation …
liver disease (NAFLD). This condition is characterized by hepatic fat accumulation …